Reported side effects are typically mild and transient: BPC-157: Nausea (rare), mild fatigue in the first week, minor injection site redness TB-500: Mild lethargy during the loading phase, transient head rush immediately after injection, injection site discomfort Combined stack: No documented synergistic toxicity in preclinical or clinical observational data The more significant risks relate to sourcing and administration rather than the peptides themselves
If any signs of injection site infection develop (increasing redness, warmth, swelling, or pain), discontinue use and consult a healthcare provider
Experience the difference at our clinic, where your well-being is our top priority
Storage & Handling Upon receipt: Keep peptides cold and away from light
A common question is whether higher-dose injections are safe compared with lower-dose pills
females of childbearing potential should discontinue semaglutide at least 2 months before a planned pregnancy due to the drugs long washout period